PAMP
BEAM icon

Polar Asset Management Partners’s Beam Therapeutics BEAM Stock Holding History

Polar Asset Management Partners’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-208,255
Closed -$5.16M – 563
2024
Q4 		$5.16M Buy
208,255
+187,455
+901% +$4.78M 0.06% 225
2024
Q3 		$510K Buy
+20,800
New +$537K 0.01% 459

Other funds holding BEAM

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Polar Asset Management Partners's BEAM Position: Q1 2025 in Review

Polar Asset Management Partners sold out of Beam Therapeutics (BEAM) in Q1 2025, closing a stake of 208,255 shares — an estimated $5.16M sold.

Polar Asset Management Partners first reported a position in BEAM in Q3 2024 and held it in 2 quarters. The position peaked at $5.16M in Q4 2024. 237 funds tracked by Wall St. Rank hold BEAM as of Q1 2025.

  • Polar Asset Management Partners reported no remaining Beam Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Polar Asset Management Partners sold 208,255 Beam Therapeutics shares in Q1 2025, an estimated $5.16M.
  • Polar Asset Management Partners first reported a position in Beam Therapeutics in Q3 2024 and held it in 2 quarters.
  • Polar Asset Management Partners's Beam Therapeutics position peaked at $5.16M in Q4 2024.
  • 237 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2025.

Based on Polar Asset Management Partners's 13F filing for Q1 2025, filed 15 May 2025.